Fang Fang1, Zhanggang Xue, Jing Cang. 1. Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Abstract
OBJECTIVE: Sevoflurane is widely used in pediatric anesthesia and former studies showed that it causes neurodegeneration in the developing brain. The present study was carried out to investigate the effects of sevoflurane on neurogenesis, neurodegeneration and behavior. METHODS: We administered 5-bromodeoxyuridine, an S-phase marker, before, during, and after 4 h of sevoflurane given to rats on postnatal day 7 to assess dentate gyrus progenitor proliferation and Fluoro-Jade staining for degeneration. Spatial reference memory was tested 2 and 6 weeks after anesthesia. RESULTS: Sevoflurane decreased progenitor proliferation and increased cell death until at least 4 days after anesthesia. Spatial reference memory was not affected at 2 weeks but was affected at 6 weeks after sevoflurane administration. CONCLUSION: Sevoflurane reduces neurogenesis and increases the death of progenitor cells in developing brain. This might mediate the late-onset neurocognitive outcome after sevoflurane application.
OBJECTIVE:Sevoflurane is widely used in pediatric anesthesia and former studies showed that it causes neurodegeneration in the developing brain. The present study was carried out to investigate the effects of sevoflurane on neurogenesis, neurodegeneration and behavior. METHODS: We administered 5-bromodeoxyuridine, an S-phase marker, before, during, and after 4 h of sevoflurane given to rats on postnatal day 7 to assess dentate gyrus progenitor proliferation and Fluoro-Jade staining for degeneration. Spatial reference memory was tested 2 and 6 weeks after anesthesia. RESULTS:Sevoflurane decreased progenitor proliferation and increased cell death until at least 4 days after anesthesia. Spatial reference memory was not affected at 2 weeks but was affected at 6 weeks after sevoflurane administration. CONCLUSION:Sevoflurane reduces neurogenesis and increases the death of progenitor cells in developing brain. This might mediate the late-onset neurocognitive outcome after sevoflurane application.
Authors: C Ikonomidou; P Bittigau; C Koch; K Genz; F Hoerster; U Felderhoff-Mueser; T Tenkova; K Dikranian; J W Olney Journal: Biochem Pharmacol Date: 2001-08-15 Impact factor: 5.858
Authors: C Ikonomidou; F Bosch; M Miksa; P Bittigau; J Vöckler; K Dikranian; T I Tenkova; V Stefovska; L Turski; J W Olney Journal: Science Date: 1999-01-01 Impact factor: 47.728
Authors: C Ikonomidou; P Bittigau; M J Ishimaru; D F Wozniak; C Koch; K Genz; M T Price; V Stefovska; F Hörster; T Tenkova; K Dikranian; J W Olney Journal: Science Date: 2000-02-11 Impact factor: 47.728
Authors: Jeffrey W Sall; Greg Stratmann; Jason Leong; William McKleroy; Daniel Mason; Shanti Shenoy; Samuel J Pleasure; Phillip E Bickler Journal: Anesthesiology Date: 2009-04 Impact factor: 7.892
Authors: Susan E Maloney; Catherine E Creeley; Richard E Hartman; Carla M Yuede; Charles F Zorumski; Vesna Jevtovic-Todorovic; Krikor Dikranian; Kevin K Noguchi; Nuri B Farber; David F Wozniak Journal: Neurobiol Learn Mem Date: 2018-03-14 Impact factor: 2.877
Authors: Eunchai Kang; Daniel A Berg; Orion Furmanski; William M Jackson; Yun Kyoung Ryu; Christy D Gray; C David Mintz Journal: Neurotoxicol Teratol Date: 2016-10-14 Impact factor: 3.763